Genmab A/S (NASDAQ:GMAB) Cut to “Hold” at Wall Street Zen
Wall Street Zen downgraded shares of Genmab A/S (NASDAQ:GMAB – Free Report) from a buy rating to a hold rating in a report released on Friday. A number of other analysts have also recently issued reports on GMAB. William Blair raised shares of Genmab A/S from a “market perform” rating to an “outperform” rating in […]
